ANI Pharmaceuticals Inc (ANIP)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The days sales outstanding (DSO) ratio for ANI Pharmaceuticals Inc for the years provided is not available in the data set. DSO is a metric used to evaluate how efficiently a company is managing its accounts receivable. A lower DSO indicates that the company is collecting its receivables more quickly, which can be a positive sign of effective cash flow management. Conversely, a higher DSO may suggest potential issues with collecting payments from customers in a timely manner. Without specific DSO values for the years in question, it is not possible to assess ANI Pharmaceuticals Inc's performance in this area. Investors and analysts typically look for trends in DSO over time to understand changes in the company's credit and collection policies, as well as its overall financial health.
Peer comparison
Dec 31, 2024